Endogenex
VerifiedDyaMX is an early stage medical device company focused on the treatment of Type 2 Diabetes.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$352—528m (Dealroom.co estimates Jun 2024.)
Minneapolis Minnesota (HQ)
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | $0.0 | round |
| N/A | $0.0 | round | |
| N/A | $0.0 | round | |
| N/A | $0.0 | round | |
* | $88.0m | Series C | |
| Total Funding | 000k | ||